Solvay S.A.
Participation notification by Blackrock Inc.
Brussels, 4 March 2021, 08:30 CET - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notification indicating that it crossed the threshold of 3%. Here is a summary of the move:
Date on which the threshold was crossed | Voting rights after the transaction | Equivalent financial instruments after the transaction | Total |
February 25, 2021 | 3.04% | 0.07% | 3.12% |
The latest notification, dated March 1, 2021, contains the following information:
- Reason for the notification: acquisition or disposal of voting securities or voting rights
- Notified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)
- Date on which the threshold is crossed: February 25, 2021
- Threshold of direct voting rights crossed: 3% upwards
- Denominator: 105,876,416
- Additional information: The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 3%.
Transparency notifications and the full chain of controlled undertakings through which the holding is effectively held is available on the Investor Relations Section of Solvay's website.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sveriges Riksbank1.7.2025 10:15:00 CEST | Press release
RESULT OF RIKSBANK CERTIFICATE SALE
ProLogium Technology Co., Ltd.1.7.2025 10:05:16 CEST | Press release
ProLogium’s Next-Generation Lithium Ceramic Battery Shipments Surpass 2.4 Million Units
Alvotech1.7.2025 10:00:00 CEST | Press release
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
Virtune AB (Publ)1.7.2025 09:30:54 CEST | Press release
Virtune is listing Virtune Coinbase 50 Index ETP on Euronext Amsterdam and Paris
Investeringsforeningen PortfolioManager1.7.2025 09:30:06 CEST | Pressemeddelelse
Investeringsforeningen PortfolioManager suspenderer handel med afdeling/andelsklasse
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom